中国老年高血压管理指南2023

[11] Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence [J]. MEDICAL JOURNAL OF AUSTRALIA, 2023, 218 (06) : 267 - 275

[12] Longitudinal real world correlation study of blood pressure and novel features of cerebral magnetic resonance angiography by artificial intelligence analysis on elderly cognitive impairment
.[J].Sun Shasha;Liu Dongyue;Zhou Yanfeng;Yang Ge;Cui Long Biao;Xu Xian;Guo Yuanhao;Sun Ting;Jiang Jiacheng;Li Na;Wang Yabin;Li Sulei;Wang Xinjiang;Fan Li;Cao Feng.Frontiers in Aging Neuroscience.2023,

[13] Prevalence; awareness; treatment; and control of hypertension in China; 2004-18: findings from six rounds of a national survey..[J].Zhang Mei;Shi Yu;Zhou Bin;Huang Zhengjing;Zhao Zhenping;Li Chun;Zhang Xiao;Han Guiyuan;Peng Ke;Li Xinhua;Wang Youfa;Ezzati Majid;Wang Limin;Li Yichong.BMJ (Clinical research ed.).2023, 8366

[14] Empagliflozin; irrespective of blood pressure; improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial..[J].Böhm Michael;Anker Stefan;Mahfoud Felix;Lauder Lucas;Filippatos Gerasimos;Ferreira João Pedro;Pocock Stuart J;Brueckmann Martina;Saloustros Ilias;Schüler Elke;Wanner Christoph;Zannad Faiez;Packer Milton;Butler Javed.European heart journal.2022, 5

[15] Hypertension treatment in the oldest-old: focus group interviews with Swedish general practitioners [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2022, 40 (03) : 395 - 404

[16] Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial [J]. LANCET, 2022, 400 (10363): : 1585 - 1596

[17] Empagliflozin in Patients with Chronic Kidney Disease..[J].Herrington William G;Staplin Natalie;Wanner Christoph;Green Jennifer B;Hauske Sibylle J;Emberson Jonathan R;Preiss David;Judge Parminder;Mayne Kaitlin J;Ng Sarah Y A;Sammons Emily;Zhu Doreen;Hill Michael;Stevens Will;Wallendszus Karl;Brenner Susanne;Cheung Alfred K;Liu ZhiHong;Li Jing;Hooi Lai Seong;Liu Wen;Kadowaki Takashi;Nangaku Masaomi;Levin Adeera;Cherney David;Maggioni Aldo P;Pontremoli Roberto;Deo Rajat;Goto Shinya;Rossello Xavier

[18] Exploring the association between cognitive decline and all-cause mortality with blood pressure as a potential modifier in oldest old individuals [J]. SCIENTIFIC REPORTS, 2022, 12 (01)

[19] Hypertension; Neurovascular Dysfunction; and Cognitive Impairment.[J].Santisteban Monica M.;Iadecola Costantino;Carnevale Daniela.Hypertension.2022,

[20] SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials [J]. LANCET, 2022, 400 (10354): : 757 - 767

[11] Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence [J]. MEDICAL JOURNAL OF AUSTRALIA, 2023, 218 (06) : 267 - 275

[12] Longitudinal real world correlation study of blood pressure and novel features of cerebral magnetic resonance angiography by artificial intelligence analysis on elderly cognitive impairment
.[J].Sun Shasha;Liu Dongyue;Zhou Yanfeng;Yang Ge;Cui Long Biao;Xu Xian;Guo Yuanhao;Sun Ting;Jiang Jiacheng;Li Na;Wang Yabin;Li Sulei;Wang Xinjiang;Fan Li;Cao Feng.Frontiers in Aging Neuroscience.2023,

[13] Prevalence; awareness; treatment; and control of hypertension in China; 2004-18: findings from six rounds of a national survey..[J].Zhang Mei;Shi Yu;Zhou Bin;Huang Zhengjing;Zhao Zhenping;Li Chun;Zhang Xiao;Han Guiyuan;Peng Ke;Li Xinhua;Wang Youfa;Ezzati Majid;Wang Limin;Li Yichong.BMJ (Clinical research ed.).2023, 8366

[14] Empagliflozin; irrespective of blood pressure; improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial..[J].Böhm Michael;Anker Stefan;Mahfoud Felix;Lauder Lucas;Filippatos Gerasimos;Ferreira João Pedro;Pocock Stuart J;Brueckmann Martina;Saloustros Ilias;Schüler Elke;Wanner Christoph;Zannad Faiez;Packer Milton;Butler Javed.European heart journal.2022, 5

[15] Hypertension treatment in the oldest-old: focus group interviews with Swedish general practitioners [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2022, 40 (03) : 395 - 404

[16] Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial [J]. LANCET, 2022, 400 (10363): : 1585 - 1596

[17] Empagliflozin in Patients with Chronic Kidney Disease..[J].Herrington William G;Staplin Natalie;Wanner Christoph;Green Jennifer B;Hauske Sibylle J;Emberson Jonathan R;Preiss David;Judge Parminder;Mayne Kaitlin J;Ng Sarah Y A;Sammons Emily;Zhu Doreen;Hill Michael;Stevens Will;Wallendszus Karl;Brenner Susanne;Cheung Alfred K;Liu ZhiHong;Li Jing;Hooi Lai Seong;Liu Wen;Kadowaki Takashi;Nangaku Masaomi;Levin Adeera;Cherney David;Maggioni Aldo P;Pontremoli Roberto;Deo Rajat;Goto Shinya;Rossello Xavier

[18] Exploring the association between cognitive decline and all-cause mortality with blood pressure as a potential modifier in oldest old individuals [J]. SCIENTIFIC REPORTS, 2022, 12 (01)

[19] Hypertension; Neurovascular Dysfunction; and Cognitive Impairment.[J].Santisteban Monica M.;Iadecola Costantino;Carnevale Daniela.Hypertension.2022,

[20] SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials [J]. LANCET, 2022, 400 (10354): : 757 - 767